nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—JAK1—hematologic cancer	0.000691	0.00175	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ADCY7—hematologic cancer	0.000688	0.00175	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-B—hematologic cancer	0.000688	0.00175	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—REL—hematologic cancer	0.000681	0.00173	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—hematologic cancer	0.000677	0.00172	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—JAK2—hematologic cancer	0.000649	0.00165	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL2RA—hematologic cancer	0.000645	0.00164	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-A—hematologic cancer	0.000638	0.00162	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNG—hematologic cancer	0.000637	0.00162	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL7—hematologic cancer	0.000631	0.0016	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—LCK—hematologic cancer	0.000603	0.00153	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—LCK—hematologic cancer	0.000579	0.00147	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ZAP70—hematologic cancer	0.000563	0.00143	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CR1—hematologic cancer	0.000563	0.00143	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HSPA5—hematologic cancer	0.000559	0.00142	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—ICAM1—hematologic cancer	0.000559	0.00142	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PTPRC—hematologic cancer	0.000547	0.00139	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CALR—hematologic cancer	0.000542	0.00137	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—JAK3—hematologic cancer	0.000537	0.00136	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PTPN11—hematologic cancer	0.000528	0.00134	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FBXW7—hematologic cancer	0.000524	0.00133	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SELL—hematologic cancer	0.000515	0.00131	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IFNA1—hematologic cancer	0.000513	0.0013	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD40—hematologic cancer	0.000508	0.00129	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ITGA4—hematologic cancer	0.000508	0.00129	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL3RA—hematologic cancer	0.000502	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CRKL—hematologic cancer	0.000502	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CBL—hematologic cancer	0.000501	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—RASGRP1—hematologic cancer	0.000499	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6R—hematologic cancer	0.000499	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—SYK—hematologic cancer	0.000498	0.00126	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HSP90AA1—hematologic cancer	0.000498	0.00126	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MX1—hematologic cancer	0.000484	0.00123	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RASGRP1—hematologic cancer	0.000479	0.00122	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TXN—hematologic cancer	0.000478	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SUMO1—hematologic cancer	0.000478	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SYK—hematologic cancer	0.000478	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD79A—hematologic cancer	0.000478	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IFNA2—hematologic cancer	0.000477	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MAP2K1—hematologic cancer	0.000475	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CD—hematologic cancer	0.000472	0.0012	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AGO2—hematologic cancer	0.000468	0.00119	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGR—hematologic cancer	0.000459	0.00116	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD34—hematologic cancer	0.000459	0.00116	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—MAPK3—hematologic cancer	0.000455	0.00115	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—GRB2—hematologic cancer	0.000449	0.00114	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PDGFA—hematologic cancer	0.000448	0.00114	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3R1—hematologic cancer	0.000446	0.00113	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BIRC3—hematologic cancer	0.000442	0.00112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BIRC2—hematologic cancer	0.000442	0.00112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ITGAL—hematologic cancer	0.000442	0.00112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KITLG—hematologic cancer	0.000442	0.00112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-DQA1—hematologic cancer	0.000441	0.00112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CARD11—hematologic cancer	0.000438	0.00111	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—JAK2—hematologic cancer	0.000433	0.0011	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ABL1—hematologic cancer	0.000432	0.00109	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—GRB2—hematologic cancer	0.000431	0.00109	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PDGFA—hematologic cancer	0.00043	0.00109	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MALT1—hematologic cancer	0.000426	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL10—hematologic cancer	0.000426	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNG—hematologic cancer	0.000425	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KITLG—hematologic cancer	0.000424	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGF19—hematologic cancer	0.000423	0.00107	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BTK—hematologic cancer	0.00042	0.00106	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD86—hematologic cancer	0.000414	0.00105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT5B—hematologic cancer	0.000413	0.00105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NUP98—hematologic cancer	0.000413	0.00105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—REL—hematologic cancer	0.000413	0.00105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CB—hematologic cancer	0.000412	0.00104	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF1—hematologic cancer	0.000401	0.00102	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ADCY7—hematologic cancer	0.000401	0.00102	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IRF8—hematologic cancer	0.000401	0.00102	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NUP214—hematologic cancer	0.000398	0.00101	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD86—hematologic cancer	0.000397	0.00101	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FOXO1—hematologic cancer	0.000395	0.001	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PDGFRB—hematologic cancer	0.000395	0.001	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NCAM1—hematologic cancer	0.00039	0.000989	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD40LG—hematologic cancer	0.00039	0.000988	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PDGFRA—hematologic cancer	0.000389	0.000986	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PRKCG—hematologic cancer	0.000387	0.000982	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—JAK1—hematologic cancer	0.000387	0.000982	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HLA-B—hematologic cancer	0.000386	0.000979	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF1—hematologic cancer	0.000385	0.000977	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD8A—hematologic cancer	0.000385	0.000977	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PML—hematologic cancer	0.00038	0.000964	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FOXO1—hematologic cancer	0.00038	0.000963	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—hematologic cancer	0.000379	0.000963	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PDGFRB—hematologic cancer	0.000379	0.000961	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL2—hematologic cancer	0.000378	0.000959	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PDGFRA—hematologic cancer	0.000373	0.000946	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-B—hematologic cancer	0.000371	0.00094	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTPN2—hematologic cancer	0.000367	0.00093	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CAMK2D—hematologic cancer	0.000357	0.000905	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—LCK—hematologic cancer	0.000351	0.000891	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PDGFB—hematologic cancer	0.000349	0.000885	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-A—hematologic cancer	0.000343	0.000871	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2L1—hematologic cancer	0.000343	0.000871	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TSC2—hematologic cancer	0.000341	0.000865	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CRP—hematologic cancer	0.000341	0.000865	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HSPA5—hematologic cancer	0.000339	0.000861	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PDGFB—hematologic cancer	0.000335	0.00085	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTPRC—hematologic cancer	0.000332	0.000841	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CALR—hematologic cancer	0.000329	0.000834	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGFR3—hematologic cancer	0.000328	0.000832	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—TSC2—hematologic cancer	0.000328	0.000831	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK14—hematologic cancer	0.000325	0.000824	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT3—hematologic cancer	0.000318	0.000807	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FBXW7—hematologic cancer	0.000318	0.000807	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—NRAS—hematologic cancer	0.000317	0.000805	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGFR3—hematologic cancer	0.000315	0.000799	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BAD—hematologic cancer	0.000311	0.000789	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NFKBIA—hematologic cancer	0.000311	0.000789	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD44—hematologic cancer	0.000308	0.000782	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD40—hematologic cancer	0.000308	0.000782	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ITGA4—hematologic cancer	0.000308	0.000782	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MAPK3—hematologic cancer	0.000304	0.000771	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CBL—hematologic cancer	0.000304	0.000771	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD80—hematologic cancer	0.000302	0.000766	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KIT—hematologic cancer	0.000301	0.000764	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ICAM1—hematologic cancer	0.000301	0.000764	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL3—hematologic cancer	0.000301	0.000763	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—BAD—hematologic cancer	0.000299	0.000758	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NFKBIA—hematologic cancer	0.000299	0.000758	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IFNA1—hematologic cancer	0.000299	0.000757	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PTPN11—hematologic cancer	0.000296	0.000751	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTPN1—hematologic cancer	0.000296	0.00075	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—RASGRP1—hematologic cancer	0.000291	0.000738	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SYK—hematologic cancer	0.00029	0.000735	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HSP90AA1—hematologic cancer	0.00029	0.000735	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD79A—hematologic cancer	0.00029	0.000735	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD80—hematologic cancer	0.00029	0.000735	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KIT—hematologic cancer	0.000289	0.000734	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FOS—hematologic cancer	0.000287	0.000729	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CREB1—hematologic cancer	0.000287	0.000727	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PTPN11—hematologic cancer	0.000284	0.000721	CbGpPWpGaD
Methyl aminolevulinate—Pain—Vincristine—hematologic cancer	0.000283	0.000467	CcSEcCtD
Methyl aminolevulinate—Rash—Melphalan—hematologic cancer	0.000282	0.000465	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Gemcitabine—hematologic cancer	0.000282	0.000465	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Melphalan—hematologic cancer	0.000282	0.000465	CcSEcCtD
Methyl aminolevulinate—Pruritus—Bleomycin—hematologic cancer	0.000281	0.000464	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CASP8—hematologic cancer	0.000281	0.000712	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Vinorelbine—hematologic cancer	0.00028	0.000463	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6R—hematologic cancer	0.00028	0.00071	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT1—hematologic cancer	0.00028	0.000709	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CREBBP—hematologic cancer	0.000279	0.000709	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Vinblastine—hematologic cancer	0.000279	0.000461	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IFNA2—hematologic cancer	0.000278	0.000705	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Irinotecan—hematologic cancer	0.000278	0.000459	CcSEcCtD
Methyl aminolevulinate—Fatigue—Mitoxantrone—hematologic cancer	0.000278	0.000459	CcSEcCtD
Methyl aminolevulinate—Pruritus—Vinorelbine—hematologic cancer	0.000276	0.000456	CcSEcCtD
Methyl aminolevulinate—Discomfort—Etoposide—hematologic cancer	0.000276	0.000456	CcSEcCtD
Methyl aminolevulinate—Pain—Irinotecan—hematologic cancer	0.000276	0.000455	CcSEcCtD
Methyl aminolevulinate—Pain—Mitoxantrone—hematologic cancer	0.000276	0.000455	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CREB1—hematologic cancer	0.000275	0.000699	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Thiotepa—hematologic cancer	0.000275	0.000454	CcSEcCtD
Methyl aminolevulinate—Rash—Lenalidomide—hematologic cancer	0.000274	0.000453	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Lenalidomide—hematologic cancer	0.000274	0.000452	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—KRAS—hematologic cancer	0.000273	0.000693	CbGpPWpGaD
Methyl aminolevulinate—Face oedema—Doxorubicin—hematologic cancer	0.000273	0.000451	CcSEcCtD
Methyl aminolevulinate—Urticaria—Alitretinoin—hematologic cancer	0.000273	0.00045	CcSEcCtD
Methyl aminolevulinate—Discomfort—Prednisolone—hematologic cancer	0.000272	0.00045	CcSEcCtD
Methyl aminolevulinate—Headache—Lenalidomide—hematologic cancer	0.000272	0.00045	CcSEcCtD
Methyl aminolevulinate—Fatigue—Gemcitabine—hematologic cancer	0.000271	0.000447	CcSEcCtD
Methyl aminolevulinate—Rash—Hydroxyurea—hematologic cancer	0.00027	0.000446	CcSEcCtD
Methyl aminolevulinate—Erythema—Dexamethasone—hematologic cancer	0.00027	0.000446	CcSEcCtD
Methyl aminolevulinate—Erythema—Betamethasone—hematologic cancer	0.00027	0.000446	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Hydroxyurea—hematologic cancer	0.00027	0.000446	CcSEcCtD
Methyl aminolevulinate—Urticaria—Ifosfamide—hematologic cancer	0.00027	0.000445	CcSEcCtD
Methyl aminolevulinate—Headache—Hydroxyurea—hematologic cancer	0.000269	0.000443	CcSEcCtD
Methyl aminolevulinate—Pain—Gemcitabine—hematologic cancer	0.000268	0.000443	CcSEcCtD
Methyl aminolevulinate—Asthenia—Thiotepa—hematologic cancer	0.000268	0.000442	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-DQA1—hematologic cancer	0.000268	0.000679	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAP2K1—hematologic cancer	0.000267	0.000676	CbGpPWpGaD
Methyl aminolevulinate—Infection—Etoposide—hematologic cancer	0.000266	0.000439	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Thalidomide—hematologic cancer	0.000266	0.000439	CcSEcCtD
Methyl aminolevulinate—Nausea—Melphalan—hematologic cancer	0.000266	0.000438	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CD—hematologic cancer	0.000265	0.000672	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Bortezomib—hematologic cancer	0.000265	0.000437	CcSEcCtD
Methyl aminolevulinate—Oedema—Prednisolone—hematologic cancer	0.000264	0.000436	CcSEcCtD
Methyl aminolevulinate—Pruritus—Thiotepa—hematologic cancer	0.000264	0.000436	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Cisplatin—hematologic cancer	0.000263	0.000434	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—GRB2—hematologic cancer	0.000262	0.000663	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PDGFA—hematologic cancer	0.000261	0.000662	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Thalidomide—hematologic cancer	0.000259	0.000427	CcSEcCtD
Methyl aminolevulinate—Dizziness—Vinorelbine—hematologic cancer	0.000258	0.000426	CcSEcCtD
Methyl aminolevulinate—Nausea—Lenalidomide—hematologic cancer	0.000258	0.000426	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Methotrexate—hematologic cancer	0.000258	0.000425	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—KITLG—hematologic cancer	0.000257	0.000652	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Mitoxantrone—hematologic cancer	0.000256	0.000422	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Carmustine—hematologic cancer	0.000255	0.000421	CcSEcCtD
Methyl aminolevulinate—Pruritus—Thalidomide—hematologic cancer	0.000255	0.000421	CcSEcCtD
Methyl aminolevulinate—Nausea—Hydroxyurea—hematologic cancer	0.000255	0.00042	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CD—hematologic cancer	0.000254	0.000645	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF2—hematologic cancer	0.000254	0.000643	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Alitretinoin—hematologic cancer	0.000253	0.000418	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Prednisone—hematologic cancer	0.000253	0.000417	CcSEcCtD
Methyl aminolevulinate—Rash—Bortezomib—hematologic cancer	0.000252	0.000416	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Bortezomib—hematologic cancer	0.000252	0.000416	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ABL1—hematologic cancer	0.000251	0.000638	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT5A—hematologic cancer	0.000251	0.000638	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CA—hematologic cancer	0.000251	0.000637	CbGpPWpGaD
Methyl aminolevulinate—Headache—Bortezomib—hematologic cancer	0.000251	0.000414	CcSEcCtD
Methyl aminolevulinate—Discomfort—Triamcinolone—hematologic cancer	0.000251	0.000414	CcSEcCtD
Methyl aminolevulinate—Rash—Bleomycin—hematologic cancer	0.00025	0.000413	CcSEcCtD
Methyl aminolevulinate—Pain—Cisplatin—hematologic cancer	0.00025	0.000413	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3R1—hematologic cancer	0.00025	0.000634	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Bleomycin—hematologic cancer	0.00025	0.000413	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Ifosfamide—hematologic cancer	0.00025	0.000413	CcSEcCtD
Methyl aminolevulinate—Asthenia—Carmustine—hematologic cancer	0.000249	0.00041	CcSEcCtD
Methyl aminolevulinate—Dizziness—Thiotepa—hematologic cancer	0.000247	0.000407	CcSEcCtD
Methyl aminolevulinate—Asthenia—Alitretinoin—hematologic cancer	0.000246	0.000407	CcSEcCtD
Methyl aminolevulinate—Rash—Vinorelbine—hematologic cancer	0.000246	0.000407	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Vinorelbine—hematologic cancer	0.000246	0.000406	CcSEcCtD
Methyl aminolevulinate—Headache—Vinorelbine—hematologic cancer	0.000245	0.000404	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Vincristine—hematologic cancer	0.000244	0.000402	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF2—hematologic cancer	0.000244	0.000618	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Ifosfamide—hematologic cancer	0.000243	0.000402	CcSEcCtD
Methyl aminolevulinate—Oedema—Triamcinolone—hematologic cancer	0.000243	0.000401	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—JAK2—hematologic cancer	0.000243	0.000617	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Alitretinoin—hematologic cancer	0.000243	0.000401	CcSEcCtD
Methyl aminolevulinate—Infection—Triamcinolone—hematologic cancer	0.000241	0.000399	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Epirubicin—hematologic cancer	0.000241	0.000398	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD86—hematologic cancer	0.000241	0.000611	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2—hematologic cancer	0.000241	0.000611	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Etoposide—hematologic cancer	0.000241	0.000397	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3R1—hematologic cancer	0.00024	0.000609	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Ifosfamide—hematologic cancer	0.00024	0.000396	CcSEcCtD
Methyl aminolevulinate—Dizziness—Thalidomide—hematologic cancer	0.000239	0.000394	CcSEcCtD
Methyl aminolevulinate—Nausea—Bortezomib—hematologic cancer	0.000238	0.000392	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Irinotecan—hematologic cancer	0.000237	0.000392	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000237	0.000392	CcSEcCtD
Methyl aminolevulinate—Asthenia—Vincristine—hematologic cancer	0.000237	0.000392	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Prednisolone—hematologic cancer	0.000237	0.000392	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MDM2—hematologic cancer	0.000237	0.000602	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HGF—hematologic cancer	0.000236	0.000599	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD40LG—hematologic cancer	0.000236	0.000599	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Bleomycin—hematologic cancer	0.000236	0.000389	CcSEcCtD
Methyl aminolevulinate—Erythema—Prednisone—hematologic cancer	0.000235	0.000388	CcSEcCtD
Methyl aminolevulinate—Rash—Thiotepa—hematologic cancer	0.000235	0.000388	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Thiotepa—hematologic cancer	0.000235	0.000388	CcSEcCtD
Methyl aminolevulinate—Headache—Thiotepa—hematologic cancer	0.000234	0.000386	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CSF2—hematologic cancer	0.000234	0.000593	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGF1—hematologic cancer	0.000234	0.000593	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD8A—hematologic cancer	0.000234	0.000593	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HRAS—hematologic cancer	0.000232	0.000589	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Vinorelbine—hematologic cancer	0.000232	0.000383	CcSEcCtD
Methyl aminolevulinate—Asthenia—Irinotecan—hematologic cancer	0.000231	0.000382	CcSEcCtD
Methyl aminolevulinate—Asthenia—Mitoxantrone—hematologic cancer	0.000231	0.000382	CcSEcCtD
Methyl aminolevulinate—Fatigue—Etoposide—hematologic cancer	0.000231	0.000381	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MTOR—hematologic cancer	0.000231	0.000586	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CB—hematologic cancer	0.000231	0.000586	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD4—hematologic cancer	0.00023	0.000585	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FOXO1—hematologic cancer	0.00023	0.000584	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PDGFRB—hematologic cancer	0.00023	0.000583	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Carmustine—hematologic cancer	0.000229	0.000378	CcSEcCtD
Methyl aminolevulinate—Pain—Etoposide—hematologic cancer	0.000229	0.000378	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MDM2—hematologic cancer	0.000228	0.000578	CbGpPWpGaD
Methyl aminolevulinate—Rash—Thalidomide—hematologic cancer	0.000228	0.000376	CcSEcCtD
Methyl aminolevulinate—Discomfort—Dexamethasone—hematologic cancer	0.000227	0.000375	CcSEcCtD
Methyl aminolevulinate—Discomfort—Betamethasone—hematologic cancer	0.000227	0.000375	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Thalidomide—hematologic cancer	0.000227	0.000375	CcSEcCtD
Methyl aminolevulinate—Dizziness—Alitretinoin—hematologic cancer	0.000227	0.000375	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PDGFRA—hematologic cancer	0.000226	0.000574	CbGpPWpGaD
Methyl aminolevulinate—Headache—Thalidomide—hematologic cancer	0.000226	0.000373	CcSEcCtD
Methyl aminolevulinate—Pain—Prednisolone—hematologic cancer	0.000226	0.000373	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PRKCG—hematologic cancer	0.000226	0.000572	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—JAK1—hematologic cancer	0.000226	0.000572	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Gemcitabine—hematologic cancer	0.000225	0.000372	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-B—hematologic cancer	0.000225	0.00057	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Ifosfamide—hematologic cancer	0.000224	0.00037	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.000223	0.000368	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6—hematologic cancer	0.000222	0.000564	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Gemcitabine—hematologic cancer	0.000222	0.000367	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CB—hematologic cancer	0.000222	0.000562	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MTOR—hematologic cancer	0.000222	0.000562	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Thiotepa—hematologic cancer	0.000222	0.000366	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD4—hematologic cancer	0.000221	0.000561	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Betamethasone—hematologic cancer	0.000221	0.000364	CcSEcCtD
Methyl aminolevulinate—Oedema—Dexamethasone—hematologic cancer	0.000221	0.000364	CcSEcCtD
Methyl aminolevulinate—Infection—Dexamethasone—hematologic cancer	0.000219	0.000362	CcSEcCtD
Methyl aminolevulinate—Infection—Betamethasone—hematologic cancer	0.000219	0.000362	CcSEcCtD
Methyl aminolevulinate—Dizziness—Vincristine—hematologic cancer	0.000219	0.000361	CcSEcCtD
Methyl aminolevulinate—Rash—Carmustine—hematologic cancer	0.000219	0.000361	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Carmustine—hematologic cancer	0.000218	0.00036	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Triamcinolone—hematologic cancer	0.000218	0.00036	CcSEcCtD
Methyl aminolevulinate—Headache—Carmustine—hematologic cancer	0.000217	0.000358	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CDKN1B—hematologic cancer	0.000217	0.00055	CbGpPWpGaD
Methyl aminolevulinate—Rash—Alitretinoin—hematologic cancer	0.000216	0.000357	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Alitretinoin—hematologic cancer	0.000216	0.000357	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Cisplatin—hematologic cancer	0.000216	0.000356	CcSEcCtD
Methyl aminolevulinate—Headache—Alitretinoin—hematologic cancer	0.000215	0.000355	CcSEcCtD
Methyl aminolevulinate—Nausea—Thalidomide—hematologic cancer	0.000214	0.000354	CcSEcCtD
Methyl aminolevulinate—Rash—Ifosfamide—hematologic cancer	0.000214	0.000353	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Ifosfamide—hematologic cancer	0.000214	0.000353	CcSEcCtD
Methyl aminolevulinate—Dizziness—Irinotecan—hematologic cancer	0.000213	0.000352	CcSEcCtD
Methyl aminolevulinate—Urticaria—Etoposide—hematologic cancer	0.000213	0.000351	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Methotrexate—hematologic cancer	0.000211	0.000349	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IL2RA—hematologic cancer	0.000211	0.000534	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Prednisolone—hematologic cancer	0.00021	0.000347	CcSEcCtD
Methyl aminolevulinate—Asthenia—Cisplatin—hematologic cancer	0.00021	0.000346	CcSEcCtD
Methyl aminolevulinate—Fatigue—Triamcinolone—hematologic cancer	0.00021	0.000346	CcSEcCtD
Methyl aminolevulinate—Rash—Vincristine—hematologic cancer	0.000209	0.000344	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Vincristine—hematologic cancer	0.000208	0.000344	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-A—hematologic cancer	0.000208	0.000528	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDKN1B—hematologic cancer	0.000208	0.000528	CbGpPWpGaD
Methyl aminolevulinate—Pain—Triamcinolone—hematologic cancer	0.000208	0.000343	CcSEcCtD
Methyl aminolevulinate—Headache—Vincristine—hematologic cancer	0.000207	0.000342	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—JUN—hematologic cancer	0.000206	0.000523	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Carmustine—hematologic cancer	0.000206	0.00034	CcSEcCtD
Methyl aminolevulinate—Nausea—Alitretinoin—hematologic cancer	0.000204	0.000337	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PDGFB—hematologic cancer	0.000203	0.000516	CbGpPWpGaD
Methyl aminolevulinate—Rash—Irinotecan—hematologic cancer	0.000203	0.000335	CcSEcCtD
Methyl aminolevulinate—Rash—Mitoxantrone—hematologic cancer	0.000203	0.000335	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Irinotecan—hematologic cancer	0.000203	0.000335	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Mitoxantrone—hematologic cancer	0.000203	0.000335	CcSEcCtD
Methyl aminolevulinate—Headache—Mitoxantrone—hematologic cancer	0.000202	0.000333	CcSEcCtD
Methyl aminolevulinate—Headache—Irinotecan—hematologic cancer	0.000202	0.000333	CcSEcCtD
Methyl aminolevulinate—Nausea—Ifosfamide—hematologic cancer	0.000202	0.000333	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CDKN1A—hematologic cancer	0.0002	0.000507	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2L1—hematologic cancer	0.0002	0.000507	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PTEN—hematologic cancer	0.000199	0.000506	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CRP—hematologic cancer	0.000199	0.000504	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TSC2—hematologic cancer	0.000199	0.000504	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Betamethasone—hematologic cancer	0.000198	0.000327	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Dexamethasone—hematologic cancer	0.000198	0.000327	CcSEcCtD
Methyl aminolevulinate—Discomfort—Prednisone—hematologic cancer	0.000198	0.000327	CcSEcCtD
Methyl aminolevulinate—Rash—Gemcitabine—hematologic cancer	0.000198	0.000327	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Gemcitabine—hematologic cancer	0.000198	0.000326	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Epirubicin—hematologic cancer	0.000198	0.000326	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Etoposide—hematologic cancer	0.000197	0.000326	CcSEcCtD
Methyl aminolevulinate—Erythema—Methotrexate—hematologic cancer	0.000197	0.000325	CcSEcCtD
Methyl aminolevulinate—Headache—Gemcitabine—hematologic cancer	0.000197	0.000325	CcSEcCtD
Methyl aminolevulinate—Nausea—Vincristine—hematologic cancer	0.000196	0.000324	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK8—hematologic cancer	0.000195	0.000495	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Prednisolone—hematologic cancer	0.000195	0.000321	CcSEcCtD
Methyl aminolevulinate—Urticaria—Triamcinolone—hematologic cancer	0.000193	0.000319	CcSEcCtD
Methyl aminolevulinate—Asthenia—Etoposide—hematologic cancer	0.000192	0.000317	CcSEcCtD
Methyl aminolevulinate—Oedema—Prednisone—hematologic cancer	0.000192	0.000317	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDKN1A—hematologic cancer	0.000192	0.000487	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PTEN—hematologic cancer	0.000192	0.000486	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Mitoxantrone—hematologic cancer	0.000191	0.000316	CcSEcCtD
Methyl aminolevulinate—Nausea—Irinotecan—hematologic cancer	0.000191	0.000316	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FGFR3—hematologic cancer	0.000191	0.000485	CbGpPWpGaD
Methyl aminolevulinate—Infection—Prednisone—hematologic cancer	0.000191	0.000315	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—EP300—hematologic cancer	0.00019	0.000483	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Dexamethasone—hematologic cancer	0.00019	0.000314	CcSEcCtD
Methyl aminolevulinate—Fatigue—Betamethasone—hematologic cancer	0.00019	0.000314	CcSEcCtD
Methyl aminolevulinate—Pruritus—Etoposide—hematologic cancer	0.00019	0.000313	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK14—hematologic cancer	0.000189	0.00048	CbGpPWpGaD
Methyl aminolevulinate—Pain—Betamethasone—hematologic cancer	0.000189	0.000311	CcSEcCtD
Methyl aminolevulinate—Pain—Dexamethasone—hematologic cancer	0.000189	0.000311	CcSEcCtD
Methyl aminolevulinate—Nausea—Gemcitabine—hematologic cancer	0.000186	0.000308	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—SRC—hematologic cancer	0.000185	0.000469	CbGpPWpGaD
Methyl aminolevulinate—Rash—Cisplatin—hematologic cancer	0.000184	0.000304	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Cisplatin—hematologic cancer	0.000184	0.000304	CcSEcCtD
Methyl aminolevulinate—Erythema—Epirubicin—hematologic cancer	0.000184	0.000304	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Doxorubicin—hematologic cancer	0.000183	0.000302	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ICAM1—hematologic cancer	0.000183	0.000463	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BAD—hematologic cancer	0.000181	0.00046	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NFKBIA—hematologic cancer	0.000181	0.00046	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Triamcinolone—hematologic cancer	0.000179	0.000296	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NRAS—hematologic cancer	0.000178	0.000451	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SRC—hematologic cancer	0.000178	0.000451	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Etoposide—hematologic cancer	0.000177	0.000293	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD80—hematologic cancer	0.000176	0.000446	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—KIT—hematologic cancer	0.000175	0.000445	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Dexamethasone—hematologic cancer	0.000175	0.000289	CcSEcCtD
Methyl aminolevulinate—Urticaria—Betamethasone—hematologic cancer	0.000175	0.000289	CcSEcCtD
Methyl aminolevulinate—Dizziness—Prednisolone—hematologic cancer	0.000175	0.000289	CcSEcCtD
Methyl aminolevulinate—Asthenia—Triamcinolone—hematologic cancer	0.000174	0.000288	CcSEcCtD
Methyl aminolevulinate—Nausea—Cisplatin—hematologic cancer	0.000174	0.000287	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Prednisone—hematologic cancer	0.000172	0.000285	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PTPN11—hematologic cancer	0.000172	0.000437	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Triamcinolone—hematologic cancer	0.000172	0.000284	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NRAS—hematologic cancer	0.000171	0.000434	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK3—hematologic cancer	0.00017	0.000432	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Doxorubicin—hematologic cancer	0.00017	0.000281	CcSEcCtD
Methyl aminolevulinate—Rash—Etoposide—hematologic cancer	0.000169	0.000279	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Etoposide—hematologic cancer	0.000169	0.000279	CcSEcCtD
Methyl aminolevulinate—Headache—Etoposide—hematologic cancer	0.000168	0.000277	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FOS—hematologic cancer	0.000167	0.000424	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CREB1—hematologic cancer	0.000167	0.000424	CbGpPWpGaD
Methyl aminolevulinate—Rash—Prednisolone—hematologic cancer	0.000167	0.000275	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Prednisolone—hematologic cancer	0.000166	0.000275	CcSEcCtD
Methyl aminolevulinate—Fatigue—Prednisone—hematologic cancer	0.000166	0.000273	CcSEcCtD
Methyl aminolevulinate—Headache—Prednisolone—hematologic cancer	0.000166	0.000273	CcSEcCtD
Methyl aminolevulinate—Discomfort—Methotrexate—hematologic cancer	0.000165	0.000273	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CASP8—hematologic cancer	0.000163	0.000415	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6R—hematologic cancer	0.000163	0.000413	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CREBBP—hematologic cancer	0.000163	0.000413	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Triamcinolone—hematologic cancer	0.000161	0.000265	CcSEcCtD
Methyl aminolevulinate—Infection—Methotrexate—hematologic cancer	0.000159	0.000263	CcSEcCtD
Methyl aminolevulinate—Nausea—Etoposide—hematologic cancer	0.000159	0.000263	CcSEcCtD
Methyl aminolevulinate—Asthenia—Betamethasone—hematologic cancer	0.000158	0.000261	CcSEcCtD
Methyl aminolevulinate—Asthenia—Dexamethasone—hematologic cancer	0.000158	0.000261	CcSEcCtD
Methyl aminolevulinate—Nausea—Prednisolone—hematologic cancer	0.000157	0.000259	CcSEcCtD
Methyl aminolevulinate—Pruritus—Betamethasone—hematologic cancer	0.000156	0.000258	CcSEcCtD
Methyl aminolevulinate—Pruritus—Dexamethasone—hematologic cancer	0.000156	0.000258	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MAP2K1—hematologic cancer	0.000155	0.000394	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Epirubicin—hematologic cancer	0.000155	0.000256	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CD—hematologic cancer	0.000154	0.000391	CbGpPWpGaD
Methyl aminolevulinate—Rash—Triamcinolone—hematologic cancer	0.000153	0.000253	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KRAS—hematologic cancer	0.000153	0.000389	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Triamcinolone—hematologic cancer	0.000153	0.000253	CcSEcCtD
Methyl aminolevulinate—Urticaria—Prednisone—hematologic cancer	0.000153	0.000252	CcSEcCtD
Methyl aminolevulinate—Headache—Triamcinolone—hematologic cancer	0.000152	0.000251	CcSEcCtD
Methyl aminolevulinate—Oedema—Epirubicin—hematologic cancer	0.00015	0.000248	CcSEcCtD
Methyl aminolevulinate—Infection—Epirubicin—hematologic cancer	0.000149	0.000246	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FGF2—hematologic cancer	0.000148	0.000375	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KRAS—hematologic cancer	0.000147	0.000373	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Betamethasone—hematologic cancer	0.000146	0.000241	CcSEcCtD
Methyl aminolevulinate—Dizziness—Dexamethasone—hematologic cancer	0.000146	0.000241	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3R1—hematologic cancer	0.000146	0.00037	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Triamcinolone—hematologic cancer	0.000144	0.000238	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Methotrexate—hematologic cancer	0.000144	0.000238	CcSEcCtD
Methyl aminolevulinate—Discomfort—Doxorubicin—hematologic cancer	0.000143	0.000236	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—JAK2—hematologic cancer	0.000142	0.000359	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Prednisone—hematologic cancer	0.000142	0.000234	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CA—hematologic cancer	0.000141	0.000357	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2—hematologic cancer	0.00014	0.000356	CbGpPWpGaD
Methyl aminolevulinate—Rash—Betamethasone—hematologic cancer	0.000139	0.00023	CcSEcCtD
Methyl aminolevulinate—Rash—Dexamethasone—hematologic cancer	0.000139	0.00023	CcSEcCtD
Methyl aminolevulinate—Oedema—Doxorubicin—hematologic cancer	0.000139	0.000229	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IFNG—hematologic cancer	0.000139	0.000353	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Betamethasone—hematologic cancer	0.000139	0.000229	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Dexamethasone—hematologic cancer	0.000139	0.000229	CcSEcCtD
Methyl aminolevulinate—Fatigue—Methotrexate—hematologic cancer	0.000138	0.000228	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MDM2—hematologic cancer	0.000138	0.000351	CbGpPWpGaD
Methyl aminolevulinate—Headache—Dexamethasone—hematologic cancer	0.000138	0.000228	CcSEcCtD
Methyl aminolevulinate—Headache—Betamethasone—hematologic cancer	0.000138	0.000228	CcSEcCtD
Methyl aminolevulinate—Infection—Doxorubicin—hematologic cancer	0.000138	0.000228	CcSEcCtD
Methyl aminolevulinate—Asthenia—Prednisone—hematologic cancer	0.000138	0.000227	CcSEcCtD
Methyl aminolevulinate—Pain—Methotrexate—hematologic cancer	0.000137	0.000227	CcSEcCtD
Methyl aminolevulinate—Pruritus—Prednisone—hematologic cancer	0.000136	0.000224	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CA—hematologic cancer	0.000135	0.000343	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Epirubicin—hematologic cancer	0.000135	0.000223	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MTOR—hematologic cancer	0.000134	0.000341	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CB—hematologic cancer	0.000134	0.000341	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD4—hematologic cancer	0.000134	0.00034	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Betamethasone—hematologic cancer	0.000131	0.000216	CcSEcCtD
Methyl aminolevulinate—Nausea—Dexamethasone—hematologic cancer	0.000131	0.000216	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HRAS—hematologic cancer	0.00013	0.00033	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Epirubicin—hematologic cancer	0.00013	0.000214	CcSEcCtD
Methyl aminolevulinate—Pain—Epirubicin—hematologic cancer	0.000128	0.000212	CcSEcCtD
Methyl aminolevulinate—Urticaria—Methotrexate—hematologic cancer	0.000128	0.00021	CcSEcCtD
Methyl aminolevulinate—Dizziness—Prednisone—hematologic cancer	0.000127	0.00021	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CDKN1B—hematologic cancer	0.000126	0.00032	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HRAS—hematologic cancer	0.000125	0.000317	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Doxorubicin—hematologic cancer	0.000125	0.000206	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6—hematologic cancer	0.000125	0.000316	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—hematologic cancer	0.000124	0.000314	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL2—hematologic cancer	0.000123	0.000313	CbGpPWpGaD
Methyl aminolevulinate—Rash—Prednisone—hematologic cancer	0.000121	0.0002	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Prednisone—hematologic cancer	0.000121	0.0002	CcSEcCtD
Methyl aminolevulinate—Headache—Prednisone—hematologic cancer	0.00012	0.000199	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—JUN—hematologic cancer	0.00012	0.000305	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Doxorubicin—hematologic cancer	0.00012	0.000198	CcSEcCtD
Methyl aminolevulinate—Urticaria—Epirubicin—hematologic cancer	0.000119	0.000197	CcSEcCtD
Methyl aminolevulinate—Pain—Doxorubicin—hematologic cancer	0.000119	0.000196	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Methotrexate—hematologic cancer	0.000118	0.000195	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CDKN1A—hematologic cancer	0.000116	0.000295	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTEN—hematologic cancer	0.000116	0.000295	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Methotrexate—hematologic cancer	0.000115	0.00019	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT1—hematologic cancer	0.000115	0.000292	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Prednisone—hematologic cancer	0.000114	0.000188	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK8—hematologic cancer	0.000114	0.000288	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Methotrexate—hematologic cancer	0.000114	0.000187	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—EP300—hematologic cancer	0.000111	0.000281	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Epirubicin—hematologic cancer	0.000111	0.000183	CcSEcCtD
Methyl aminolevulinate—Urticaria—Doxorubicin—hematologic cancer	0.00011	0.000182	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT1—hematologic cancer	0.00011	0.00028	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Epirubicin—hematologic cancer	0.000108	0.000178	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—SRC—hematologic cancer	0.000108	0.000273	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Epirubicin—hematologic cancer	0.000106	0.000175	CcSEcCtD
Methyl aminolevulinate—Dizziness—Methotrexate—hematologic cancer	0.000106	0.000175	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—STAT3—hematologic cancer	0.000104	0.000264	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NRAS—hematologic cancer	0.000104	0.000263	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Doxorubicin—hematologic cancer	0.000102	0.000169	CcSEcCtD
Methyl aminolevulinate—Rash—Methotrexate—hematologic cancer	0.000101	0.000167	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Methotrexate—hematologic cancer	0.000101	0.000167	CcSEcCtD
Methyl aminolevulinate—Headache—Methotrexate—hematologic cancer	0.000101	0.000166	CcSEcCtD
Methyl aminolevulinate—Asthenia—Doxorubicin—hematologic cancer	9.97e-05	0.000165	CcSEcCtD
Methyl aminolevulinate—Dizziness—Epirubicin—hematologic cancer	9.93e-05	0.000164	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK3—hematologic cancer	9.93e-05	0.000252	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Doxorubicin—hematologic cancer	9.83e-05	0.000162	CcSEcCtD
Methyl aminolevulinate—Nausea—Methotrexate—hematologic cancer	9.53e-05	0.000157	CcSEcCtD
Methyl aminolevulinate—Rash—Epirubicin—hematologic cancer	9.47e-05	0.000156	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Epirubicin—hematologic cancer	9.46e-05	0.000156	CcSEcCtD
Methyl aminolevulinate—Headache—Epirubicin—hematologic cancer	9.41e-05	0.000155	CcSEcCtD
Methyl aminolevulinate—Dizziness—Doxorubicin—hematologic cancer	9.19e-05	0.000152	CcSEcCtD
Methyl aminolevulinate—Nausea—Epirubicin—hematologic cancer	8.92e-05	0.000147	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—KRAS—hematologic cancer	8.92e-05	0.000226	CbGpPWpGaD
Methyl aminolevulinate—Rash—Doxorubicin—hematologic cancer	8.76e-05	0.000145	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Doxorubicin—hematologic cancer	8.76e-05	0.000145	CcSEcCtD
Methyl aminolevulinate—Headache—Doxorubicin—hematologic cancer	8.71e-05	0.000144	CcSEcCtD
Methyl aminolevulinate—Nausea—Doxorubicin—hematologic cancer	8.26e-05	0.000136	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CA—hematologic cancer	8.2e-05	0.000208	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HRAS—hematologic cancer	7.58e-05	0.000192	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6—hematologic cancer	7.26e-05	0.000184	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT1—hematologic cancer	6.7e-05	0.00017	CbGpPWpGaD
